Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Consent for Use of Stored Patient Specimens for Future Testing
NCT00031408 · View on ClinicalTrials.gov ↗
Study Summary
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other tissues) for future studies that may include genetic testing.
Conditions Studied
Study Locations (20)
California
- Univ of Southern California / LA County USC Med Ctr — Los Angeles
- Charles Drew Medical Center — Los Angeles
- UCLA CARE Ctr — Los Angeles
- Univ of California, San Diego — San Diego
- Univ of California San Francisco — San Francisco
- San Mateo AIDS Program / Stanford Univ — Stanford
- Stanford Univ Med Ctr — Stanford
- Willow Clinic / Stanford Univ — Stanford
- Harbor General/UCLA — Torrance
Illinois
- Northwestern Univ Med School — Chicago
- Rush Presbyterian - Saint Luke's Med Ctr — Chicago
- The CORE Ctr — Chicago
Indiana
- Indiana Univ Hosp — Indianapolis
- Methodist Hosp of Indiana / Life Care Clinic — Indianapolis
- Wishard Hosp — Indianapolis
Colorado
- Univ of Colorado Health Sciences Ctr — Denver
District of Columbia
- Georgetown Univ Med Ctr — Washington D.C.
Florida
- Univ of Miami School of Medicine — Miami
Georgia
- Emory Univ — Atlanta
Iowa
- Department of Internal Medicine, University of Iowa Hospitals & Clinics CRS (1504) — Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17,444 participants |
| Start Date | 2002-02-13 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00031408
The ClinicalTrials.gov registry entry for NCT00031408 describes a study currently listed as active not recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 17,444 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, which has 15 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT00031408 reports 20 study locations spanning 8 distinct geographic areas — top geographies include California, Illinois, Indiana. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT00031408 about?
NCT00031408 is a clinical study titled "Consent for Use of Stored Patient Specimens for Future Testing". The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other tissues) for future studies that may include genetic testing.
What is the current status of trial NCT00031408?
This trial is currently active not recruiting. The enrollment target is 17,444 participants. The study started on 2002-02-13. Estimated completion is 2027-12-31.
What conditions does trial NCT00031408 study?
This clinical trial studies the following conditions: HIV Infections. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT00031408?
This trial is sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, which has 15 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT00031408 being conducted?
This trial has 20 study locations across California, Colorado, District of Columbia, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.